About SOLIGENIX, INC.
Soligenix is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases with unmet medical needs. The company operates in two segments: specialized biotherapeutics and public health solutions.
Development of orphan and unmet medical need indicationsPreclinical, manufacturing, regulatory, and clinical expertiseThermostable vaccine development for global useBiodefense and infectious disease applications
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| Federal contract award | Department of Health and Human Services | $21.2M |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to SOLIGENIX, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.